|
Email:
|
ivana.gotthardova@upjs.sk | |
|
Homepage:
|
https://www.upjs.sk/LF/zamestnanec/ivana.gotthardova | |
|
Faculty:
|
LF UPJŠ
-
Pavol Jozef Šafárik University in Košice Faculty of Medicine
|
|
|
Department:
|
4. IK
-
4th Department of Internal Medicine
|
|
|
Office:
|
HE2O316 | |
|
Phone:
|
||
|
ORCID ID:
|
0000-0001-5575-2101 |
|
Profile courses
|
|
Internal medicine 1 - dental medicine, I.+II. degree
|
|
Internal medicine 2 - General medicine, I.+II. degree
|
|
Internal medicine 3 - general medicine, I.+II. degree
|
|
Internal medicine 4 - General medicine, I.+II. degree
|
|
nternal medicine 5 - General medicine, I.+II. degree
|
|
Selected publications
|
|
ADC - Javorský M, Gotthardová I, Klimčáková L, Kvapil M, Židzik J, Schroner Z, Doubravová P, Gala I, Dravecká I, Tkáč I. A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins. Diabetes Obes Metab. 2016 Sep;18(9):941-4. doi: 10.1111/dom.12682. Epub 2016 Jun 7. PMID: 27160388. IF 5,9; Q1; Citované: 28-krát.
|
|
ADC - Tkáč I, Gotthardová I. Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers. Pharmacogenomics. 2016 May;17(7):795-804. doi: 10.2217/pgs-2016-0011. Epub 2016 May 11. PMID: 27166975. IF 2,35; Q2; Citované: 11-krát.
|
|
ADC - Gotthardová I, Javorský M, Klimčáková L, Kvapil M, Schroner Z, Kozárová M, Malachovská Z, Ürgeová A, Židzik J, Tkáč I. KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors. Diabetes Res Clin Pract. 2017 Aug;130:142-147. doi: 10.1016/j.diabres.2017.05.018. Epub 2017 May 19. PMID: 28624668. IF 4,568; Q1; Citované: 15-krát.
|
|
ADC - Űrgeová A, Javorský M, Klimčáková L, Židzik J, Šalagovič J, Hubáček JA, Doubravová P, Gotthardová I, Kvapil M, Pelikánová T, Tkáč I, Yaluri AS. Genetic variants associated with glycemic response to treatment with dipeptidylpeptidase 4 inhibitors. Pharmacogenomics. 2020 Apr;21(5):317-323. doi: 10.2217/pgs-2019-0147. Epub 2020 Apr 20. PMID: 32308134. IF 2,35; Q2; Citované: 4-krát.
|
|
BFA1 - Javorský M, Gotthardová I, Űrgeová A, Klimčáková L, Doubravová P, Hubáček J, Židzik J, Dravecká I, Kvapil M, Pelikánová T, Tkáč I. GLP1R gene variant is associated with glycemic preponse to treatment with DPP-4 inhibitors. Projekt: Sledovanie asociácií vybraných génových variantov s odpoveďou na liečbu orálnymi antidiabetikami gliptínmi - VEGA 1/0027/16. In: 7th Meeting of EASD Study Group on Genetics of Diabetes (EASD-SGGD) : Programme & Abstract Book. - Praha : EASD, 2019. - S. 87-87.
|
|
Selected projects
|
|
VEGA 2014 1/0389/14: Monitoring the relationship of variants of selected candidate atherosclerosis genes to the severity of peripheral arterial obliterative disease of the lower limbs in type 2 diabetics - Principal investigator: Miriam Kozárová, Implemented; co-solver |
|
VEGA 2016 1/0027/16: Monitoring of associations of selected gene variants with response to treatment with oral antidiabetics gliptins - Principal investigator: Ivan Tkáč; Implemented; co-solver |
|
VEGA: 1/0183/20. Monitoring of genomic and proteomic markers of atherosclerosis in limb and carotid arteries in type 2 diabetes. Main researcher: prof. MUDr. Ivan Tkáč, Ph.D. Duration: 2020-2023; co-solver |
|
Excellent Atherosclerosis Research Team (EXTASY) - https://www.upjs.sk/university/research/scientific-and- research-activities-phd-studies/top-research-teams/extasy/ |
|
Organisational activities
|
|
member - Slovak Diabetological Society, 2015-
|
|
member - Slovak Society of Endocrinology, 2021-
|
